Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
about
sameAs
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancerVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesDiagnosis and Treatment of Lower Extremity Deep Vein Thrombosis: Korean Practice GuidelinesLow-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic reviewGuidelines on oral anticoagulation (warfarin): third edition--2005 update.Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.Essay for the CIHR/CMAJ award: the role of low-molecular-weight heparin therapy venous thromboembolism.
P2860
Q24194904-A39CAE06-27F2-4878-944F-DD7B2D2FD9C5Q24632982-0517A5C6-B8D9-4C7D-B45B-7DF0CB7DC8D2Q24633053-7FD1EEB4-0F14-41B1-ACD7-BBE031054F79Q28072833-E3ACD6EC-A2A8-4C4D-9CCB-E2C95B24D58BQ33380411-7915D76F-7BE3-4FDA-8C15-980BE891B3E3Q34484090-6E56FCA1-FDAF-465D-B76E-90A49BDB3BA2Q36471056-55840D0F-0C8E-45BD-A7A2-8A58BC24365CQ38664988-FE999332-D4A2-46E1-BFB0-77CB073EE6AFQ41903910-41C5C1A2-4B13-4A71-9E44-1C674CFA3C13
P2860
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@ast
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@en
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@nl
type
label
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@ast
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@en
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@nl
altLabel
Vitamin K antagonists or low-m ...... tomatic venous thromboembolism
@en
Vitamin K antagonists or low-m ...... tomatic venous thromboembolism
@nl
prefLabel
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@ast
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@en
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@nl
P2093
P2860
P1476
Vitamin K antagonists or low-m ...... tomatic venous thromboembolism
@en
Vitamin K antagonists or low-m ...... omatic venous thromboembolism.
@en
P2093
B A Hutten
H R Büller
J F van der Heijden
van Der Heijden JF
P2860
P304
P356
10.1002/14651858.CD002001
P407
P577
2000-01-01T00:00:00Z
2002-01-01T00:00:00Z